BHC Bausch Health Companies Inc

  1. Stocks
  2. Healthcare
  3. NYSE: BHC

Price (delayed)

$28.6

Market cap

$10.25B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.86

Enterprise value

$32.1B

Highlights
The debt has declined by 2.8% year-on-year
The net income has plunged by 82% from the previous quarter but it has grown by 46% YoY
BHC's EPS has dropped by 81% since the previous quarter but it is up by 47% year-on-year
The company's equity has shrunk by 137% QoQ and by 127% YoY
BHC's gross profit is down by 8% year-on-year
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: https://www.bauschhealth.com
Peers: ONTX OPK

Key stats

What are the main financial stats of BHC
Market
Shares outstanding
358.4M
Market cap
$10.25B
Enterprise value
$32.1B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.27
EV/EBIT
207.07
EV/EBITDA
16.87
EV/Sales
3.99
Earnings
Revenue
$8.04B
EBIT
$155M
EBITDA
$1.9B
Free cash flow
$988M
Per share
EPS
-$2.86
Free cash flow per share
$2.77
Book value per share
-$0.55
Revenue per share
$22.54
TBVPS
$27.23
Balance sheet
Total assets
$30.2B
Total liabilities
$30.32B
Debt
$23.74B
Equity
-$197M
Working capital
$494M
Liquidity
Debt to equity
-120.5
Current ratio
1.1
Quick ratio
0.69
Net debt/EBITDA
11.49
Margins
EBITDA margin
23.7%
Gross margin
71.4%
Net margin
-12.7%
Operating margin
2.6%
Efficiency
Return on assets
-3.3%
Return on equity
-291.1%
Return on invested capital
0.6%
Return on capital employed
0.6%
Return on sales
1.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BHC stock price

How has the Bausch Health Companies stock price performed over time
Intraday
0.03%
1 week
3.59%
1 month
-1.65%
1 year
68.04%
YTD
37.5%
QTD
-2.46%

Financial performance

How have Bausch Health Companies's revenue and profit performed over time
Revenue
$8.04B
Gross profit
$5.74B
Operating income
$207M
Net income
-$1.02B
Gross margin
71.4%
Net margin
-12.7%
The operating margin has soared by 193% YoY but it has plunged by 69% from the previous quarter
The company's operating income has surged by 186% YoY but it has shrunk by 69% QoQ
The net income has plunged by 82% from the previous quarter but it has grown by 46% YoY
The net margin has dropped by 81% since the previous quarter but it has increased by 42% year-on-year

Growth

What is Bausch Health Companies's growth rate over time

Valuation

What is Bausch Health Companies stock price valuation
P/E
N/A
P/B
N/A
P/S
1.27
EV/EBIT
207.07
EV/EBITDA
16.87
EV/Sales
3.99
BHC's EPS has dropped by 81% since the previous quarter but it is up by 47% year-on-year
The company's equity has shrunk by 137% QoQ and by 127% YoY
The price to sales (P/S) is 59% higher than the 5-year quarterly average of 0.8 and 27% higher than the last 4 quarters average of 1.0
The revenue has declined by 6% year-on-year

Efficiency

How efficient is Bausch Health Companies business performance
The ROE has plunged by 165% YoY
BHC's return on sales has surged by 156% year-on-year but it has dropped by 75% since the previous quarter
BHC's return on invested capital has surged by 155% year-on-year but it has dropped by 73% since the previous quarter
The ROA has plunged by 83% from the previous quarter but it has grown by 43% YoY

Dividends

What is BHC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BHC.

Financial health

How did Bausch Health Companies financials performed over time
Bausch Health Companies's quick ratio has decreased by 7% YoY
Bausch Health Companies's total assets has decreased by 5% YoY and by 3.2% QoQ
The company's equity has shrunk by 137% QoQ and by 127% YoY
The debt has declined by 2.8% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.